The incidence of hepatitis flare and hepatic decompensation after nucleos(t)ide analogue cessation in chronic hepatitis B patients

被引：0
|
作者：
Dongelmans, Edo J. [1 ]
Janssen, Harry L. A. [1 ,2 ]
机构：
[1] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Univ Hlth Network, Toronto Gen Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada
来源：
JOURNAL OF HEPATOLOGY | 2025年 / 82卷 / 04期
关键词：
D O I：
10.1016/j.jhep.2024.11.044
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：e174 / e175
页数：2
相关论文
共 50 条
  • [41] VIROLOGICAL AND CLINICAL OUTCOMES AFTER CESSATION OF NUCLEOS(T)IDE ANALOGUE THERAPY FOR CHRONIC HEPATITIS B - A PROSPECTIVE COHORT STUDY IN CENTRAL TAIWAN
    Yen, Chieh-Ling
    Su, Wei-Wen
    Wu, Chih-Sheng
    Chen, Shih-Tien
    Yan, Sheng-Li
    Peng, Cheng-Yuan
    Lin, Chun-Che
    Huang, Jen-Chieh
    Chen, Tsung-Ming
    Liao, Kuan-Fu
    GUT, 2018, 67 : A105 - A105
  • [42] 48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse
    Xu, Wen-xiong
    Zhang, Qian
    Zhu, Xiang
    Lin, Chao-shuang
    Chen, You-ming
    Deng, Hong
    Mei, Yong-yu
    Zhao, Zhi-xin
    Xie, Dong-ying
    Gao, Zhi-liang
    Xie, Chan
    Peng, Liang
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 2019
  • [43] Dysregulation of miRNA in chronic hepatitis B is associated with HCC risk after nucleos( t) ide analogue treatment
    Suzuki, Hiromu
    Takahashi, Hideaki
    Wakasugi, Hideki
    Niinuma, Takeshi
    Kitajima, Hiroshi
    Yamamoto, Eiichiro
    Sasaki, Hajime
    Sudo, Gouta
    Kai, Masahiro
    Tokino, Takashi
    Nakase, Hiroshi
    Ito, Fumio
    CANCER SCIENCE, 2018, 109 : 692 - 692
  • [44] Chronic hepatitis B: peginterferon or nucleos(t)ide analogues?
    Sonneveld, Milan J.
    Janssen, Harry L. A.
    LIVER INTERNATIONAL, 2011, 31 : 78 - 84
  • [45] The Baseline and On treatment Predictive Factors of Hepatitis B Relapse after Nucleos(t)ide Analogue Discontinuation in Chronic Hepatitis B: A Prospective study
    Kaewdech, Apichat
    Sripongpun, Pimsiri
    Jundee, Sawangpong
    Chamroonkul, Naichaya
    Piratvisuth, Teerha
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 236 - 236
  • [46] Chronic hepatitis B: a scoping review on the guidelines for stopping nucleos(t)ide analogue therapy
    Hui, Rex Wan-Hin
    Mak, Lung-Yi
    Seto, Wai-Kay
    Yuen, Man-Fung
    Fung, James
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 17 (05) : 443 - 450
  • [47] Hepatitis B Virus-Specific T Cells as a Biomarker for Discontinuation of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
    Tian, Yongjun
    Ou, Jing-hsiung James
    HEPATOLOGY, 2019, 69 (03) : 1342 - 1344
  • [48] Relapse incidence and severe flares in chronic hepatitis B patients with lymphoma post rituximab-based chemotherapy versus HBeAg-negative hepatitis B patients without cancer after nucleos (t)ide analogue cessation
    Liu, Yen-Chun
    Shih, Yu-Jia
    Jeng, Rachel Wen-Juei
    Hsu, Chao-Wei
    Chien, Rong-Nan
    JOURNAL OF HEPATOLOGY, 2024, 80 : S772 - S772
  • [49] The 96-week clinical outcomes after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients
    Xu, Wen-Xiong
    Li, Yang-Mei
    Li, Jian-Guo
    Mei, Yong-Yu
    Chen, You-Ming
    Li, Xue-Jun
    Lin, Chao-Shuang
    Deng, Hong
    Zhao, Zhi-Xin
    Xie, Dong-Ying
    Gao, Zhi-Liang
    Peng, Liang
    GASTROENTEROLOGY REPORT, 2021, 9 (04): : 313 - 322
  • [50] Treatment of chronic hepatitis B with nucleos(t)ide analogues
    Ohishi, Waka
    Chayama, Kazuaki
    HEPATOLOGY RESEARCH, 2012, 42 (03) : 219 - 225
12345